Regeneron Pharmaceuticals | REGN - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
AbbVie USD 3.84B 205M 2026-09
Agenus USD 6.21M 4.34M 2026-03
Agios Pharmaceuticals USD 51.55M 13.09M 2026-06
Alnylam Pharmaceuticals USD 342M 5.92M 2026-09
Amgen USD 1.68B 40M 2026-09
Astellas Pharma JPY 215.29B 225M 2026-09
AstraZeneca USD 4.07B 1.73B 2026-09
Biogen USD 752M 42.3M 2026-09
BioMarin Pharmaceutical USD 333.64M 61.91M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Eli Lilly USD 3.12B 305M 2026-09
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
Incyte USD 364.27M 12.54M 2026-09
Ionis Pharmaceuticals USD 154M 23.92M 2026-09
J&J USD 6.25B 168M 2026-09
Kyowa Hakko Kirin JPY 38.91B 4.83B 2026-09
Merck USD 2.86B 25M 2026-09
Moderna USD 282M 66M 2026-09
Neurocrine Biosciences USD 366.3M 16.8M 2026-09
Novartis USD 3.08B 163M 2026-09
Novartis USD 3.08B 58M 2026-09
Pfizer USD 3.28B 132M 2026-09
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.63B 140M 2026-06
Sarepta Therapeutics USD 118.61M 11.01M 2026-09
Teva Pharmaceutical Industries USD 1.01B 27M 2026-09
Ultragenyx Pharmaceutical USD 97M 9M 2026-09
United Therapeutics USD 184.1M 22.6M 2026-09
Vertex Pharmaceuticals USD 556.3M 25.9M 2026-09